Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies
- 10 May 2007
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (15) , 3777-3788
- https://doi.org/10.1016/j.molimm.2007.03.023
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Preclinical Manufacture of Anti-HER2 Liposome-Inserting, scFv-PEG-Lipid Conjugate. 2. Conjugate Micelle Identity, Purity, Stability, and Potency AnalysisBiotechnology Progress, 2008
- Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and PurificationBiotechnology Progress, 2008
- A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometryEuropean Journal Of Cancer, 2005
- Intracellular targeting and functional analysis of single-chain Fv fragments in mammalian cellsMethods, 2004
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Towards proteome-wide production of monoclonal antibody by phage displayJournal of Molecular Biology, 2002
- FPRP, a Major, Highly Stoichiometric, Highly Specific CD81- and CD9-associated ProteinJournal of Biological Chemistry, 2001
- Selection of tumor-specific internalizing human antibodies from phage librariesJournal of Molecular Biology, 2000
- Toward Selection of Internalizing Antibodies from Phage LibrariesBiochemical and Biophysical Research Communications, 1999
- By-passing immunizationJournal of Molecular Biology, 1991